New centers for disease control and prevention's guidelines on HIV counseling and testing for the general population and pregnant women

被引:7
|
作者
Phillips, KA
Bayer, R
Chen, JL
机构
[1] Univ Calif San Francisco, Res Sch Pharm, Inst Hlth Policy Studies, San Francisco, CA 94143 USA
[2] Univ Calif Davis, Davis, CA 95616 USA
[3] Columbia Univ, New York, NY USA
关键词
HIV counseling and testing; CDC counseling and testing guidelines; perinatal counseling and testing guidelines;
D O I
10.1097/00126334-200302010-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We review two new HIV counseling and testing guidelines by the U.S. Centers for Disease Control and Prevention. The guidelines, which address the general population and pregnant women, reflect an important shift in the goals and methods of counseling and testing that has widespread implications. The guidelines' defining characteristic is the greater emphasis on increasing the numbers of people knowing their HIV status while maintaining the historical focus on extensive pretest counseling and consent procedures. We discuss the policy and practice implications by evaluating five factors: 1) Will the guidelines be adopted? 2) Will at-risk and infected individuals be identified for counseling and testing? 3) Will health care providers offer counseling and testing and patients accept counseling and testing, obtain their test results, seek treatment, and change risky behaviors? 4) Will the guidelines be relatively cost-effective? 5) Will the guidelines be compatible with ethical standards?
引用
收藏
页码:182 / 191
页数:10
相关论文
共 50 条
  • [31] Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines
    Workowski, Kimberly A.
    Berman, Stuart M.
    CLINICAL INFECTIOUS DISEASES, 2011, 53 : S59 - S63
  • [32] Experience and barriers of counseling, testing and prevention of HIV in the practice of general practitioners in Ukraine
    Voronova, K.
    Kvasnevska, Y.
    Lopatina, Y.
    Zakowicz, A. M.
    HIV MEDICINE, 2023, 24 : 45 - 45
  • [33] New guidelines for heart disease prevention in women
    Mosca, L
    Appel, LJ
    Benjamin, EJ
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (11) : 825 - 826
  • [34] Intended Target of the Centers for Disease Control and Prevention Opioid Guidelines
    Meghani, Salimah H.
    JAMA ONCOLOGY, 2016, 2 (09) : 1243 - 1243
  • [35] The Contribution of HIV Testing Funded by the Centers for Disease Control and Prevention to HIV Diagnoses in the United States, 2010–2017
    Weston Williams
    Amy Krueger
    Guoshen Wang
    Deesha Patel
    Lisa Belcher
    Journal of Community Health, 2021, 46 : 832 - 841
  • [36] Assessing the implementation of infection prevention and control at HIV counseling and testing facilities
    Ondieki, J. M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E381 - E382
  • [37] Patient and Clinician Ethical Perspectives on the 2006 Centers for Disease Control and Prevention HIV Testing Methods
    Merchant, Roland C.
    Waxman, Michael J.
    Maher, Julie G.
    Clark, Melissa A.
    Celada, M. Teresa
    Liu, Tao
    Simmons, Emma M.
    Beckwith, Curt G.
    Mayer, Kenneth H.
    PUBLIC HEALTH REPORTS, 2012, 127 (03) : 318 - 329
  • [38] Perspectives on the ethical concerns and justifications of the 2006 Centers for Disease Control and Prevention HIV testing recommendations
    Waxman, Michael J.
    Merchant, Roland C.
    Celada, M. Teresa
    Clark, Melissa A.
    BMC MEDICAL ETHICS, 2011, 12
  • [39] Perspectives on the ethical concerns and justifications of the 2006 Centers for Disease Control and Prevention HIV testing recommendations
    Michael J Waxman
    Roland C Merchant
    M Teresa Celada
    Melissa A Clark
    BMC Medical Ethics, 12
  • [40] Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV
    Hawkins, D
    Blott, M
    Clayden, P
    de Ruiter, A
    Foster, G
    Gilling-Smith, C
    Gosrani, B
    Lyall, H
    Mercey, D
    Newell, ML
    O'Shea, S
    Smith, R
    Sunderland, J
    Wood, C
    Taylor, G
    HIV MEDICINE, 2005, 6 : 107 - 148